MedTrace Logo

An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea

NCT01828177 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2014-05-29

No results posted yet for this study

Summary

This 4-arm Phase 2 vehicle-controlled study is designed to assess the safety and efficacy of PDI-320, and the individual components, in adult subjects with rosacea.

Conditions

  • Rosacea

Interventions

DRUG

PDI-320

DRUG

PDI-320 Monad #1

DRUG

PDI-320 Monad #2

DRUG

Vehicle

Sponsors & Collaborators

  • PreCision Dermatology, Inc.

    lead INDUSTRY

Principal Investigators

  • Syd Dromgoole, PhD · Therapeutics, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01828177 on ClinicalTrials.gov